BBC vs LABU

Virtus Biotech Clinical Trials ETF against Direxion Daily S&P Biotech Bull 3X ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
28%
75 shared positions
Fee gap
—
same fee
1-year return gap
70.6 pts
LABU is ahead
Larger fund
LABU
$553M

Side by side

BBCLABU
FundVirtus Biotech Clinical Trials ETFDirexion Daily S&P Biotech Bull 3X ETF
IssuerVirtusDirexion
CategoryBiotech & Health InnovationLeveraged Equity
Expense ratio0.65%—
Assets$42M$553M
Average daily dollar volume$866K$105M
ListedDec 16, 2014May 28, 2015
FrenzyCap score4484
1-month return−11.6%−8.6%
3-month return−14.0%−10.9%
Year to date+14.5%+52.5%
1-year return+52.3%+123.0%
30-day volatility32.2%81.8%
Worst drawdown, 1 year−22.8%−34.7%
Trailing 12-month yield1.49%0.37%
Holdings125173
Top 10 weight16.2%248.9%
Look-through P/E——
Holdings vs fair value+16.7%+5.8%
Holdings above 200-day average46%62%
Net flow, latest 3 reported months+$5.1M thru Jul 2026−$198M thru Jul 2026
30-day implied volatility43.3%94.0%
Holdings as ofas of Apr 30, 2026SEC filingas of Oct 9, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

62% of BBC · 30% of LABU
HoldingBBCLABU
SYRE1.64%1.09%
RVMD1.35%1.07%
ERAS2.19%1.04%
ORKA1.68%1.00%
KOD1.35%0.97%
PCVX0.95%1.03%
DNTH1.54%0.91%
PRAX0.88%0.90%
CGON1.21%0.78%
PTGX0.77%1.13%
CYTK0.75%0.99%
TNGX1.71%0.73%
RLAY1.19%0.68%
BEAM0.82%0.68%
KYMR0.67%0.94%
CELC0.85%0.65%
COGT0.63%0.94%
VKTX0.62%0.76%
SRRK0.73%0.61%
DYN0.67%0.57%
RXRX0.59%0.53%
IMVT0.76%0.51%
SMMT0.90%0.50%
IDYA0.63%0.46%
DNLI0.77%0.46%

Sector mix of the stock holdings

SectorBBCLABUGap
Health Care92.6%77.2%+15.4%
Technology0.6%0.0%+0.6%
Financials0.0%0.5%−0.5%

More: full overlap table · BBC holdings · LABU holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.